{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T18:23:46Z","timestamp":1791397426712,"version":"4.3.3"},"reference-count":95,"publisher":"Elsevier BV","issue":"6","content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seminars in Cancer Biology"],"published-print":{"date-parts":[[2013,12]]},"DOI":"10.1016\/j.semcancer.2013.08.004","type":"journal-article","created":{"date-parts":[[2013,8,30]],"date-time":"2013-08-30T21:27:13Z","timestamp":1377898033000},"page":"457-467","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":99,"special_numbering":"PA","title":["Lymphomas occurring specifically in HIV-infected patients: From pathogenesis to pathology"],"prefix":"10.1016","volume":"23","author":[{"given":"Annunziata","family":"Gloghini","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Riccardo","family":"Dolcetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonino","family":"Carbone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.semcancer.2013.08.004_bib0005","series-title":"World Health Organization classification of tumours, pathology and genetics of tumours of haematopoietic and lymphoid tissues","first-page":"340","article-title":"Lymphomas associated with HIV infection","author":"Raphael","year":"2008"},{"key":"10.1016\/j.semcancer.2013.08.004_bib0010","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1182\/blood-2008-09-180315","article-title":"HIV-associated lymphomas and gamma-herpesviruses","volume":"113","author":"Carbone","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.semcancer.2013.08.004_bib0015","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/S0140-6736(07)61050-2","article-title":"Incidence of cancers in people with HIV\/AIDS compared with immunosuppressed transplant recipients: a meta-analysis","volume":"370","author":"Grulich","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.semcancer.2013.08.004_bib0020","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1136\/jcp.2007.051953","article-title":"HIV infection and lymphoma","volume":"60","author":"Grogg","year":"2007","journal-title":"J Clin Pathol"},{"key":"10.1016\/j.semcancer.2013.08.004_bib0025","doi-asserted-by":"crossref","first-page":"3406","DOI":"10.1182\/blood.V98.12.3406","article-title":"Non-Hodgkin lymphoma in HIV-infected patients in the era of highly active antiretroviral therapy","volume":"98","author":"Kirk","year":"2001","journal-title":"Blood"},{"key":"10.1016\/j.semcancer.2013.08.004_bib0030","first-page":"605","article-title":"AIDS-related non-Hodgkin lymphoma: still a problem in the era of HAART","volume":"14","author":"Aboulafia","year":"2004","journal-title":"AIDS Read"},{"key":"10.1016\/j.semcancer.2013.08.004_bib0035","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1086\/592170","article-title":"Progressive telomere shortening of Epstein\u2013Barr virus-specific memory T cells during HIV infection: contributor to exhaustion","volume":"198","author":"Van Baarle","year":"2008","journal-title":"J Infect Dis"},{"key":"10.1016\/j.semcancer.2013.08.004_bib0040","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1097\/00001622-200209000-00009","article-title":"B-cell activation and lymphoma in patients with HIV","volume":"14","author":"Mart\u00ednez-Maza","year":"2002","journal-title":"Curr Opin Oncol"},{"key":"10.1016\/j.semcancer.2013.08.004_bib0045","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1200\/JCO.1993.11.6.1099","article-title":"Parameters affecting the development of non-Hodgkin's lymphoma in patients with severe human immunodeficiency virus infection receiving antiretroviral therapy","volume":"11","author":"Pluda","year":"1993","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.semcancer.2013.08.004_bib0050","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1158\/1055-9965.EPI-11-0037","article-title":"B-cell stimulatory cytokines and markers of immune activation are elevated several years prior to the diagnosis of systemic AIDS-associated non-Hodgkin B-cell lymphoma","volume":"20","author":"Breen","year":"2011","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/j.semcancer.2013.08.004_bib0055","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1200\/JCO.2009.25.1322","article-title":"Circulating serum free light chains as predictive markers of AIDS-related lymphoma","volume":"28","author":"Landgren","year":"2010","journal-title":"J Clin Oncol"},{"issue":"9822","key":"10.1016\/j.semcancer.2013.08.004_bib0060","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1016\/S0140-6736(11)61177-X","article-title":"Burkitt's lymphoma","volume":"379","author":"Molyneux","year":"2012","journal-title":"Lancet"},{"key":"10.1016\/j.semcancer.2013.08.004_bib0065","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.3324\/haematol.12705","article-title":"Molecular analysis of immunoglobulin variable genes in human immunodeficiency virus-related non-Hodgkin's lymphoma reveals implications for disease pathogenesis and histogenesis","volume":"93","author":"Capello","year":"2008","journal-title":"Haematologica"},{"key":"10.1016\/j.semcancer.2013.08.004_bib0070","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1016\/0046-8177(95)90192-2","article-title":"Human immunodeficiency virus-associated Hodgkin's disease contains latent, not replicative, Epstein\u2013Barr virus","volume":"26","author":"Siebert","year":"1995","journal-title":"Hum Pathol"},{"key":"10.1016\/j.semcancer.2013.08.004_bib0075","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1097\/COH.0b013e32831a722b","article-title":"HIV-associated Hodgkin lymphoma","volume":"4","author":"Carbone","year":"2009","journal-title":"Curr Opin HIV AIDS"},{"key":"10.1016\/j.semcancer.2013.08.004_bib0080","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/ajcp\/91.1.1","article-title":"A survey of Epstein\u2013Barr virus DNA in lymphoid tissue. Frequent detection in Hodgkin's disease","volume":"91","author":"Staal","year":"1989","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.semcancer.2013.08.004_bib0085","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1002\/ijc.2910490313","article-title":"Epstein\u2013Barr virus antibody patterns preceding the diagnosis of non-Hodgkin's lymphoma","volume":"49","author":"Mueller","year":"1991","journal-title":"Int J Cancer"},{"key":"10.1016\/j.semcancer.2013.08.004_bib0090","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1182\/blood.V98.1.146","article-title":"Dysfunctional Epstein\u2013Barr virus (EBV)-specific CD8(+) T lymphocytes and increased EBV load in HIV infected individuals progressing to AIDS-related non-Hodgkin lymphoma","volume":"98","author":"van Baarle","year":"2001","journal-title":"Blood"},{"key":"10.1016\/j.semcancer.2013.08.004_bib0095","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1097\/01.cco.0000239882.23839.e5","article-title":"Pathogenesis of AIDS lymphoma: role of oncogenic viruses and B cell activation-associated molecular lesions","volume":"18","author":"Epeldegui","year":"2006","journal-title":"Curr Opin Oncol"},{"key":"10.1016\/j.semcancer.2013.08.004_bib0100","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1002\/jmv.2071","article-title":"Quantification of Epstein\u2013Barr virus load in peripheral blood of human immunodeficiency virus-infected patients using real-time PCR","volume":"65","author":"Dehee","year":"2001","journal-title":"J Med Virol"},{"key":"10.1016\/j.semcancer.2013.08.004_bib0105","doi-asserted-by":"crossref","first-page":"6931","DOI":"10.4049\/jimmunol.172.11.6931","article-title":"Altered EBV viral load setpoint after HIV seroconversion is in accordance with lack of predictive value of EBV load for the occurrence of AIDS-related non-Hodgkin lymphoma","volume":"172","author":"Piriou","year":"2004","journal-title":"J Immunol"},{"key":"10.1016\/j.semcancer.2013.08.004_bib0110","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1086\/341460","article-title":"Absolute level of Epstein\u2013Barr virus DNA in human immunodeficiency virus type 1 infection is not predictive of AIDS-related non-Hodgkin lymphoma","volume":"186","author":"Van Baarle","year":"2002","journal-title":"J Infect Dis"},{"key":"10.1016\/j.semcancer.2013.08.004_bib0115","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.1086\/656479","article-title":"Changes in blood B cell phenotypes and Epstein\u2013Barr virus load in chronically human immunodeficiency virus-infected patients before and after antiretroviral therapy","volume":"202","author":"Richard","year":"2010","journal-title":"J Infect Dis"},{"key":"10.1016\/j.semcancer.2013.08.004_bib0120","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/j.semcancer.2013.07.005","article-title":"Viral antigens and cellular pathways interplay in the development of EBV-driven lymphomas","volume":"23","author":"Dolcetti","year":"2013","journal-title":"Seminars Cancer Biol"},{"key":"10.1016\/j.semcancer.2013.08.004_bib0125","doi-asserted-by":"crossref","first-page":"9150","DOI":"10.1073\/pnas.90.19.9150","article-title":"Epstein\u2013Barr virus latent membrane protein 1 is essential for B-lymphocyte growth transformation","volume":"90","author":"Kaye","year":"1993","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.semcancer.2013.08.004_bib0130","doi-asserted-by":"crossref","first-page":"13984","DOI":"10.1128\/JVI.79.22.13984-13992.2005","article-title":"Epstein\u2013Barr virus lytic infection is required for efficient production of the angiogenesis factor vascular endothelial growth factor in lymphoblastoid cell lines","volume":"79","author":"Hong","year":"2005","journal-title":"J Virol"},{"key":"10.1016\/j.semcancer.2013.08.004_bib0135","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1128\/JVI.01512-10","article-title":"A new model of Epstein\u2013Barr virus infection reveals an important role for early lytic viral protein expression in the development of lymphomas","volume":"85","author":"Ma","year":"2011","journal-title":"J Virol"},{"key":"10.1016\/j.semcancer.2013.08.004_bib0140","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1084\/jem.20031467","article-title":"KSHV vFLIP is essential for the survival of infected lymphoma cells","volume":"199","author":"Guasparri","year":"2004","journal-title":"J Exp Med"},{"key":"10.1016\/j.semcancer.2013.08.004_bib0145","doi-asserted-by":"crossref","first-page":"2510","DOI":"10.1182\/blood-2004-08-3052","article-title":"Inhibiting primary effusion lymphoma by lentiviral vectors encoding short hairpin RNA","volume":"105","author":"Godfrey","year":"2005","journal-title":"Blood"},{"issue":"5293","key":"10.1016\/j.semcancer.2013.08.004_bib0150","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1126\/science.274.5293.1739","article-title":"Molecular mimicry of human cytokine and cytokine response pathway genes by KSHV","volume":"274","author":"Moore","year":"1996","journal-title":"Science"},{"key":"10.1016\/j.semcancer.2013.08.004_bib0155","doi-asserted-by":"crossref","first-page":"4034","DOI":"10.1182\/blood.V93.12.4034","article-title":"Angiogenesis and hematopoiesis induced by Kaposi's sarcoma-associated herpesvirus-encoded interleukin-6","volume":"93","author":"Aoki","year":"1999","journal-title":"Blood"},{"key":"10.1016\/j.semcancer.2013.08.004_bib0160","doi-asserted-by":"crossref","first-page":"2871","DOI":"10.1182\/blood.V94.8.2871","article-title":"Involvement of interleukin-10 (IL-10) and viral IL-6 in the spontaneous growth of Kaposi's sarcoma herpesvirus-associated infected primary effusion lymphoma cells","volume":"94","author":"Jones","year":"1999","journal-title":"Blood"},{"issue":"6590","key":"10.1016\/j.semcancer.2013.08.004_bib0165","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1038\/382410a0","article-title":"Cyclin encoded by KS herpesvirus","volume":"382","author":"Chang","year":"1996","journal-title":"Nature"},{"key":"10.1016\/j.semcancer.2013.08.004_bib0170","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1182\/blood-2005-06-2534","article-title":"KSHV viral cyclin inactivates p27KIP1 through Ser10 and Thr187 phosphorylation in proliferating primary effusion lymphomas","volume":"107","author":"Sarek","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.semcancer.2013.08.004_bib0175","doi-asserted-by":"crossref","first-page":"2430","DOI":"10.1128\/MCB.26.6.2430-2440.2006","article-title":"Phosphorylation of the cyclin-dependent kinase inhibitor p21Cip1 on serine 130 is essential for viral cyclin-mediated bypass of a p21Cip1-imposed G1 arrest","volume":"26","author":"J\u00e4rviluoma","year":"2006","journal-title":"Mol Cell Biol"},{"issue":"6764","key":"10.1016\/j.semcancer.2013.08.004_bib0180","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1038\/47266","article-title":"p53 inhibition by the LANA protein of KSHV protects against cell death","volume":"402","author":"Friborg","year":"1999","journal-title":"Nature"},{"key":"10.1016\/j.semcancer.2013.08.004_bib0185","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1038\/80459","article-title":"The latent nuclear antigen of Kaposi sarcoma-associated herpesvirus targets the retinoblastoma-E2F pathway and with the oncogene HRAS transforms primary rat cells","volume":"6","author":"Radkov","year":"2000","journal-title":"Nat Med"},{"key":"10.1016\/j.semcancer.2013.08.004_bib0190","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1172\/JCI30945","article-title":"Reactivation of the p53 pathway as a treatment modality for KSHV-induced lymphomas","volume":"117","author":"Sarek","year":"2007","journal-title":"J Clin Invest"},{"key":"10.1016\/j.semcancer.2013.08.004_bib0195","doi-asserted-by":"crossref","first-page":"10451","DOI":"10.1128\/JVI.00804-07","article-title":"The Kaposi's sarcoma-associated herpesvirus LANA protein stabilizes and activates c-Myc","volume":"81","author":"Liu","year":"2007","journal-title":"J Virol"},{"key":"10.1016\/j.semcancer.2013.08.004_bib0200","doi-asserted-by":"crossref","first-page":"4979","DOI":"10.1038\/sj.onc.1210299","article-title":"Deregulation of c-Myc in primary effusion lymphoma by Kaposi's sarcoma herpesvirus latency-associated nuclear antigen","volume":"26","author":"Bubman","year":"2007","journal-title":"Oncogene"},{"key":"10.1016\/j.semcancer.2013.08.004_bib0205","article-title":"Recruitment of the tumour suppressor protein p73 by Kaposi's Sarcoma Herpesvirus latent nuclear antigen contributes to the survival of primary effusion lymphoma cells","author":"Santag","year":"2012","journal-title":"Oncogene"},{"key":"10.1016\/j.semcancer.2013.08.004_bib0210","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1128\/JVI.75.1.429-438.2001","article-title":"Kaposi's sarcoma-associated herpesvirus LANA2 is a B-cell-specific latent viral protein that inhibits p53","volume":"75","author":"Rivas","year":"2001","journal-title":"J Virol"},{"issue":"Pt 6","key":"10.1016\/j.semcancer.2013.08.004_bib0215","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1099\/vir.0.19014-0","article-title":"The latency protein LANA2 from Kaposi's sarcoma-associated herpesvirus inhibits apoptosis induced by dsRNA-activated protein kinase but not RNase L activation","volume":"84","author":"Esteban","year":"2003","journal-title":"J Gen Virol"},{"key":"10.1016\/j.semcancer.2013.08.004_bib0220","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1182\/blood-2007-05-092288","article-title":"The viral interferon-regulatory factor-3 is required for the survival of KSHV-infected primary effusion lymphoma cells","volume":"111","author":"Wies","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.semcancer.2013.08.004_bib0225","doi-asserted-by":"crossref","first-page":"12836","DOI":"10.1128\/JVI.01804-07","article-title":"Kaposi's sarcoma-associated herpesvirus encodes an ortholog of miR-155","volume":"81","author":"Skalsky","year":"2007","journal-title":"J Virol"},{"key":"10.1016\/j.semcancer.2013.08.004_bib0230","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1038\/nature05992","article-title":"A viral microRNA functions as an orthologue of cellular miR-155","volume":"450","author":"Gottwein","year":"2007","journal-title":"Nature"},{"key":"10.1016\/j.semcancer.2013.08.004_bib0235","doi-asserted-by":"crossref","first-page":"11698","DOI":"10.1128\/JVI.06855-11","article-title":"A Kaposi's sarcoma-associated herpesvirus microRNA and its variants target the transforming growth factor \u03b2 pathway to promote cell survival","volume":"86","author":"Lei","year":"2012","journal-title":"J Virol"},{"key":"10.1016\/j.semcancer.2013.08.004_bib0240","doi-asserted-by":"crossref","first-page":"3931","DOI":"10.4049\/jimmunol.176.7.3931","article-title":"HIV-1 envelope triggers polyclonal Ig class switch recombination through a CD40-independent mechanism involving BAFF and C-type lectin receptors","volume":"176","author":"He","year":"2006","journal-title":"J Immunol"},{"key":"10.1016\/j.semcancer.2013.08.004_bib0245","doi-asserted-by":"crossref","first-page":"5872","DOI":"10.1128\/JVI.02542-06","article-title":"Tremblay MJ.Human immunodeficiency virus type 1-associated CD40 ligand transactivates B lymphocytes and promotes infection of CD4+ T cells","volume":"81","author":"Martin","year":"2007","journal-title":"J Virol"},{"key":"10.1016\/j.semcancer.2013.08.004_bib0250","doi-asserted-by":"crossref","first-page":"2189","DOI":"10.1128\/JVI.01993-10","article-title":"Acquisition of host-derived CD40L by HIV-1 in vivo and its functional consequences in the B-cell compartment","volume":"85","author":"Imbeault","year":"2011","journal-title":"J Virol"},{"key":"10.1016\/j.semcancer.2013.08.004_bib0255","first-page":"1","article-title":"Functions of the HIV-1 matrix protein p17","volume":"29","author":"Fiorentini","year":"2006","journal-title":"New Microbiol"},{"key":"10.1016\/j.semcancer.2013.08.004_bib0260","doi-asserted-by":"crossref","first-page":"e17831","DOI":"10.1371\/journal.pone.0017831","article-title":"Opposite effects of HIV-1 p17 variants on PTEN activation and cell growth in B cells","volume":"6","author":"Giagulli","year":"2011","journal-title":"PLoS ONE"},{"key":"10.1016\/j.semcancer.2013.08.004_bib0265","doi-asserted-by":"crossref","first-page":"14807","DOI":"10.1073\/pnas.0506857102","article-title":"Persistence of HIV-1 structural proteins and glycoproteins in lymph nodes of patients under highly active antiretroviral therapy","volume":"102","author":"Popovic","year":"2005","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.semcancer.2013.08.004_bib0270","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1634\/theoncologist.11-4-375","article-title":"Burkitt's lymphoma: clinicopathologic features and differential diagnosis","volume":"11","author":"Ferry","year":"2006","journal-title":"Oncologist"},{"key":"10.1016\/j.semcancer.2013.08.004_bib0275","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1182\/blood.V97.3.744","article-title":"Expression profile of MUM1\/IRF4, BCL-6, and CD138\/syndecan-1 defines novel histogenetic subsets of human immunodeficiency virus-related lymphomas","volume":"97","author":"Carbone","year":"2001","journal-title":"Blood"},{"key":"10.1016\/j.semcancer.2013.08.004_bib0280","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1634\/theoncologist.2008-0036","article-title":"EBV-associated lymphoproliferative disorders: classification and treatment","volume":"13","author":"Carbone","year":"2008","journal-title":"Oncologist"},{"key":"10.1016\/j.semcancer.2013.08.004_bib0285","doi-asserted-by":"crossref","first-page":"1674","DOI":"10.1200\/JCO.1993.11.9.1674","article-title":"Human immunodeficiency virus-associated systemic lymphomas may be subdivided into two main groups according to Epstein\u2013Barr viral latent gene expression","volume":"11","author":"Carbone","year":"1993","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.semcancer.2013.08.004_bib0290","series-title":"Monographs on the Evaluation of Carcinogenic Risks to Humans. A Review of Human Carcinogens. Part B: Biological Agents\/IARC Working Group on the Evaluation of Carcinogenic Risks to Humans, vol. 100","author":"IARC","year":"2012"},{"key":"10.1016\/j.semcancer.2013.08.004_bib0295","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1002\/ijc.24655","article-title":"B-cell differentiation in EBV-positive Burkitt lymphoma is impaired at posttranscriptional level by miRNA-altered expression","volume":"126","author":"Leucci","year":"2010","journal-title":"Int J Cancer"},{"key":"10.1016\/j.semcancer.2013.08.004_bib0300","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1002\/path.2410","article-title":"MYC translocation-negative classical Burkitt lymphoma cases: an alternative pathogenetic mechanism involving miRNA deregulation","volume":"216","author":"Leucci","year":"2008","journal-title":"J Pathol"},{"key":"10.1016\/j.semcancer.2013.08.004_bib0305","doi-asserted-by":"crossref","first-page":"4115","DOI":"10.1182\/blood-2002-10-3090","article-title":"Gene expression profile analysis of AIDS-related primary effusion lymphoma (PEL) suggests a plasmablastic derivation and identifies PEL-specific transcripts","volume":"101","author":"Klein","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.semcancer.2013.08.004_bib0310","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1182\/blood.V100.4.1113.h81602001113_1113_1122","article-title":"Generation of polyclonal plasmablasts from peripheral blood B cells: a normal counterpart of malignant plasmablasts","volume":"100","author":"Tarte","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.semcancer.2013.08.004_bib0315","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1182\/blood-2002-10-3161","article-title":"Gene expression profiling of plasma cells and plasmablasts: toward a better understanding of the late stages of B-cell differentiation","volume":"102","author":"Tarte","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.semcancer.2013.08.004_bib0320","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1056\/NEJM199505043321802","article-title":"Kaposi's sarcoma-associated herpesvirus-like DNA sequences in AIDS-related body-cavity-based lymphomas","volume":"332","author":"Cesarman","year":"1995","journal-title":"N Engl J Med"},{"key":"10.1016\/j.semcancer.2013.08.004_bib0325","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1182\/blood.V88.2.645.bloodjournal882645","article-title":"Primary effusion lymphoma: a distinct clinicopathologic entity associated with the kaposi's sarcoma-associated herpes virus","volume":"88","author":"Nador","year":"1996","journal-title":"Blood"},{"key":"10.1016\/j.semcancer.2013.08.004_bib0330","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1111\/j.1365-2141.2007.06879.x","article-title":"KSHV\/HHV8-associated lymphomas","volume":"140","author":"Carbone","year":"2008","journal-title":"Br J Haematol"},{"key":"10.1016\/j.semcancer.2013.08.004_bib0335","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1097\/QAD.0b013e3283365395","article-title":"Understanding pathogenetic aspects and clinical presentation of primary effusion lymphoma through its derived cell lines","volume":"24","author":"Carbone","year":"2010","journal-title":"AIDS"},{"key":"10.1016\/j.semcancer.2013.08.004_bib0340","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/S0065-230X(01)80014-2","article-title":"Primary effusion lymphoma: a liquid phase lymphoma of fluid-filled body cavities","volume":"80","author":"Gaidano","year":"2001","journal-title":"Adv Cancer Res"},{"key":"10.1016\/j.semcancer.2013.08.004_bib0345","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1136\/jcp.2007.047969","article-title":"Kaposi sarcoma-associated herpesvirus\/human herpesvirus 8 and lymphoproliferative disorders","volume":"60","author":"Du","year":"2007","journal-title":"J Clin Pathol"},{"key":"10.1016\/j.semcancer.2013.08.004_bib0350","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/S0065-230X(08)60775-7","article-title":"Epidemiology of kaposi's sarcoma-associated herpesvirus\/human herpesvirus 8","volume":"76","author":"Schulz","year":"1999","journal-title":"Adv Cancer Res"},{"key":"10.1016\/j.semcancer.2013.08.004_bib0355","doi-asserted-by":"crossref","first-page":"3948","DOI":"10.1200\/JCO.2003.06.013","article-title":"Clinical features and outcome of primary effusion lymphoma in HIV-infected patients: a single-institution study","volume":"21","author":"Simonelli","year":"2003","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.semcancer.2013.08.004_bib0360","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1128\/JVI.79.2.1244-1251.2005","article-title":"Distinct subsets of primary effusion lymphoma can be identified based on their cellular gene expression profile and viral association","volume":"79","author":"Fan","year":"2005","journal-title":"J Virol"},{"key":"10.1016\/j.semcancer.2013.08.004_bib0365","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1002\/cncr.23597","article-title":"HHV8-unrelated effusion lymphomas: classification and diagnosis","volume":"114","author":"Carbone","year":"2008","journal-title":"Cancer"},{"key":"10.1016\/j.semcancer.2013.08.004_bib0370","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1159\/000097460","article-title":"Comparison of human herpes virus 8 related primary effusion lymphoma with human herpes virus 8 unrelated primary effusion lymphoma-like lymphoma on the basis of HIV: report of 2 cases and review of 212 cases in the literature","volume":"117","author":"Kobayashi","year":"2007","journal-title":"Acta Haematol"},{"key":"10.1016\/j.semcancer.2013.08.004_bib0375","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1002\/cncr.22691","article-title":"Primary effusion lymphoma: a series of 4 cases and review of the literature with emphasis on cytomorphologic and immunocytochemical differential diagnosis","volume":"111","author":"Brimo","year":"2007","journal-title":"Cancer"},{"key":"10.1016\/j.semcancer.2013.08.004_bib0380","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1038\/modpathol.3880012","article-title":"Human herpesvirus 8-associated solid lymphomas that occur in AIDS patients take anaplastic large cell morphology","volume":"13","author":"Katano","year":"2000","journal-title":"Mod Pathol"},{"key":"10.1016\/j.semcancer.2013.08.004_bib0385","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1097\/01.MP.0000056629.62148.55","article-title":"Immunoblastic lymphoma in persons with AIDS-associated kaposi's sarcoma: a role for kaposi's sarcoma-associated herpesvirus","volume":"16","author":"Engels","year":"2003","journal-title":"Mod Pathol"},{"key":"10.1016\/j.semcancer.2013.08.004_bib0390","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1097\/01.pas.0000138177.10829.5c","article-title":"KSHV-positive solid lymphomas represent an extra-cavitary variant of primary effusion lymphoma","volume":"28","author":"Chadburn","year":"2004","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.semcancer.2013.08.004_bib0395","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/S1525-1578(10)60004-9","article-title":"Kaposi's sarcoma-associated herpesvirus\/human herpesvirus type 8-positive solid lymphomas: a tissue-based variant of primary effusion lymphoma","volume":"7","author":"Carbone","year":"2005","journal-title":"J Mol Diagn"},{"key":"10.1016\/j.semcancer.2013.08.004_bib0400","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1016\/j.humpath.2003.11.005","article-title":"Oral solid form of primary effusion lymphoma mimicking plasmablastic lymphoma","volume":"35","author":"Mate","year":"2004","journal-title":"Hum Pathol"},{"key":"10.1016\/j.semcancer.2013.08.004_bib0405","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1016\/S0046-8177(03)00093-5","article-title":"Anorectal lymphoma without effusion associated with human herpesvirus-8 and type 1 Epstein\u2013Barr virus in an HIV-infected patient","volume":"34","author":"Navarro","year":"2003","journal-title":"Hum Pathol"},{"key":"10.1016\/j.semcancer.2013.08.004_bib0410","doi-asserted-by":"crossref","first-page":"149","DOI":"10.3816\/CLM.2005.n.044","article-title":"Extracavitary primary effusion lymphoma of the anorectum","volume":"6","author":"Pantanowitz","year":"2005","journal-title":"Clin Lymphoma Myeloma"},{"key":"10.1016\/j.semcancer.2013.08.004_bib0415","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1007\/s12308-012-0148-6","article-title":"Early lesion in lymphoid neoplasia","volume":"5","author":"Fend","year":"2012","journal-title":"J Hematopathol"},{"key":"10.1016\/j.semcancer.2013.08.004_bib0420","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1182\/blood.V95.4.1406.004k26_1406_1412","article-title":"HHV-8 is associated with a plasmablastic variant of castleman disease that is linked to HHV-8-positive plasmablastic lymphoma","volume":"95","author":"Dupin","year":"2000","journal-title":"Blood"},{"key":"10.1016\/j.semcancer.2013.08.004_bib0425","series-title":"World Health Organization classification of tumours, pathology and genetics of tumours of haematopoietic and lymphoid tissues","first-page":"258","article-title":"Large B-cell lymphoma arising in HHV8-associated multicentric Castleman disease","author":"Isaacson","year":"2008"},{"key":"10.1016\/j.semcancer.2013.08.004_bib0430","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1182\/blood.V89.4.1413","article-title":"Plasmablastic lymphomas of the oral cavity: a new entity associated with the human immunodeficiency virus infection","volume":"89","author":"Delecluse","year":"1997","journal-title":"Blood"},{"key":"10.1016\/j.semcancer.2013.08.004_bib0435","series-title":"World Health Organization classification of tumours, pathology and genetics of tumours of haematopoietic and lymphoid tissues","first-page":"256","article-title":"Plasmablastic lymphoma","author":"Stein","year":"2008"},{"key":"10.1016\/j.semcancer.2013.08.004_bib0440","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1002\/ajh.21250","article-title":"HIV-associated plasmablastic lymphoma: lessons learned from 112 published cases","volume":"83","author":"Castillo","year":"2008","journal-title":"Am J Hematol"},{"key":"10.1016\/j.semcancer.2013.08.004_bib0445","first-page":"448","article-title":"Editorial comment: plasmablastic lymphoma \u2013 a diagnostic and therapeutic puzzle","volume":"17","author":"Pantanowitz","year":"2007","journal-title":"AIDS Read"},{"key":"10.1016\/j.semcancer.2013.08.004_bib0450","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1111\/j.1601-0825.2008.01493.x","article-title":"Plasmablastic lymphoma: a review","volume":"15","author":"Rafaniello Raviele","year":"2009","journal-title":"Oral Dis"},{"key":"10.1016\/j.semcancer.2013.08.004_bib0455","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/S1473-3099(08)70067-7","article-title":"Plasmablastic lymphoma of the oral cavity: a rapidly progressive lymphoma associated with HIV infection","volume":"8","author":"Riedel","year":"2008","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.semcancer.2013.08.004_bib0460","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1177\/000348949910800115","article-title":"AIDS-related plasmablastic lymphomas of the oral cavity and jaws: a diagnostic dilemma","volume":"108","author":"Carbone","year":"1999","journal-title":"Ann Otol Rhinol Laryngol"},{"key":"10.1016\/j.semcancer.2013.08.004_bib0465","doi-asserted-by":"crossref","first-page":"1538","DOI":"10.1097\/01.pas.0000131533.21345.1c","article-title":"Is plasmablastic lymphoma of the oral cavity an HHV-8-associated disease?","volume":"28","author":"Carbone","year":"2004","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.semcancer.2013.08.004_bib0470","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1097\/01.pas.0000126781.87158.e3","article-title":"Diffuse large B-cell lymphomas with plasmablastic differentiation represent a heterogeneous group of disease entities","volume":"28","author":"Colomo","year":"2004","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.semcancer.2013.08.004_bib0475","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1007\/s11912-005-0062-5","article-title":"Diffuse large B-cell lymphomas with plasmablastic differentiation","volume":"7","author":"Teruya-Feldstein","year":"2005","journal-title":"Curr Oncol Rep"}],"container-title":["Seminars in Cancer Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1044579X13000801?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1044579X13000801?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,5,17]],"date-time":"2024-05-17T14:12:42Z","timestamp":1715955162000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1044579X13000801"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,12]]},"references-count":95,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2013,12]]}},"alternative-id":["S1044579X13000801"],"URL":"https:\/\/doi.org\/10.1016\/j.semcancer.2013.08.004","relation":{},"ISSN":["1044-579X"],"issn-type":[{"value":"1044-579X","type":"print"}],"subject":[],"published":{"date-parts":[[2013,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Lymphomas occurring specifically in HIV-infected patients: From pathogenesis to pathology","name":"articletitle","label":"Article Title"},{"value":"Seminars in Cancer Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.semcancer.2013.08.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}